Proteostasis disruption and lipid dyshomeostasis in neurodegeneration: exploring common druggable targets across sporadic and monogenic disorders
Priscila Pereira Sena(University of Tübingen), Thorsten Schmidt(University of Tübingen), Alcibiades E. Villarreal(Secretaría Nacional de Ciencia, Tecnología e Innovación), Maria Luiza Saraiva Pereira(Universidade Federal do Rio Grande do Sul), Florian Fath(University of Tübingen), Mar Hernández‐Guillamón(Vall d'Hebron Institut de Recerca), Gabrielle B. Britton(Universidad de Panamá), Liubovi Sopco(Vall d'Hebron Institut de Recerca), Jonasz Jeremiasz Weber(University Hospitals of the Ruhr-University of Bochum)
Cited by 3
Related Papers
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis
|The Lancet Neurology|2004|1.1k
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
|Nature Reviews Neurology|2019|924
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
|The Lancet Neurology|2022|651
Transgenic rat model of Huntington's disease
|Human Molecular Genetics|2003|349